JPMorgan US Small Company Fund

277 Park Avenue,
New York , NY, 10172

Rank

Rank Universe

Summary

The fund seeks high total return by investing in small-size companies in the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in equity securities of U.S. companies.

An issuer of a security will be deemed to be located in the United States if: the principal trading market for the security is in the United States, or the i

Link

Directors

Sep 13, 2023
  • Robert F. Deutsch
  • Marian U. Pardo
  • Robert J. Grassi
  • Marilyn McCoy
  • Raymond Kanner
  • Lawrence R. Maffia
  • Kathleen M. Gallagher
  • Dr. Robert A. Oden, Jr.
  • Nina O. Shenker
  • Stephen P. Fisher
  • Gary L. French
  • Mary E. Martinez
  • John F. Finn
  • Frankie D. Hughes
  • Thomas P. Lemke
  • Emily A. Youssouf

Chief Compliance Officer

  • Stephen M. Ungerman

Fund Manager(s)

Price

  • $19.12 ( +0.05 ) Nov 1, 2024 Last Close
  • Net Assets
  • $0.9B
    Feb 28, 2024
    More
  • 52-Week High/Low
  • $0 - $0
  • Turnover
  • 52%
  • Expense Ratio
  • 0.82%

Company Name

Holding

Medpace Holdings, Inc. 0.71 %
AvePoint, Inc. 0.5 %
Oscar Health, Inc. 0.44 %
Oddity Tech Ltd. 0.42 %
Hut 8 Corp. 0.41 %
Insmed, Inc. 0.39 %
RxSight, Inc. 0.39 %
Madrigal Pharmaceuticals, Inc. 0.36 %
Vita Coco Co., Inc. (The) 0.36 %
Atrion Corp. 0.35 %
More

Documents

Prospectus

Annual Reports

Performance

YTD

5.3%

3 Year

-24.01%

5 Year

12.01%

Best

21.27%

2019

Worst

-21.42%

2022

Alpha

JUSYX Russell 2000 Index

Chart +